SecBot SecBot

EXAS

EXACT SCIENCES CORP
Nasdaq· Services-Medical Laboratories· CIK 0001124140 Healthcare & Medical Devices
No price
Median target
$105.00
range $105.00–118.00
Insider net
$0
no open-market trades · since Mar 23
New fund stakes
0
Q2 2026 13F · 1 exit
Filing reports
4
analyzed by SecBot
Congress trades
1
disclosed
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Mar 23. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.103 → $0.050 over 90 days. 1 up, 1 down in 30 days.

Who's buying

13F· Q2 2026
0
new positions
1
exit
FundMoveSharesValue
NORGES BANKEXIT0$0.00
VAN ECK ASSOCIATES CORPNEAR_EXIT20,917$2.2M
WEALTH ENHANCEMENT ADVISORY SERVICES, LLCNEAR_EXIT11,481$1.2M
HUNTINGTON NATIONAL BANKNEAR_EXIT1$1.9K
FMR LLCEXIT0$0.00
MORGAN STANLEYEXIT0$0.00
BANK OF AMERICA CORP /DE/EXIT0$0.00
CHARLES SCHWAB INVESTMENT MANAGEMENT INCEXIT0$0.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Jan 2026
Recent actions
DateFirmActionRating
Jan 20, 2026Mizuho
DOWNGRADE
DOWNGRADENeutral
Jan 5, 2026Evercore ISI Group
DOWNGRADE
DOWNGRADEIn-Line
Nov 28, 2025Stifel
DOWNGRADE
DOWNGRADEHold
Nov 25, 2025Canaccord Genuity
DOWNGRADE
DOWNGRADEHold
Nov 24, 2025Benchmark
DOWNGRADE
DOWNGRADEHold
Nov 24, 2025Jefferies
DOWNGRADE
DOWNGRADEHold

Insider ledger

Form 4
$0
open-market buys or sells · since Mar 23
DateInsiderTypeValue
Mar 23, 2026
COWARD D SCOTT
Director
Mar 23, 2026
TO ISSUER5,398 sh
Mar 23, 2026
Trigg Leslie
Director
Mar 23, 2026
TO ISSUER13,925 sh
Mar 23, 2026
Barber Michael J
Director
Mar 23, 2026
TO ISSUER7,422 sh
Mar 23, 2026
Clancy Paul J
Director
Mar 23, 2026
TO ISSUER20,640 sh
Mar 23, 2026
COWARD D SCOTT
Director
Mar 23, 2026
TO ISSUER10,786 sh
Mar 23, 2026
Herriott James
SVP, General Counsel & Sec
Mar 23, 2026
TO ISSUER2,861 sh
Mar 23, 2026
Conroy Kevin T
President and CEO
Mar 23, 2026
AWARD119,312 sh
Mar 23, 2026
Herriott James
SVP, General Counsel & Sec
Mar 23, 2026
TO ISSUER793 sh

Earnings setup

Estimates
$0.05
EPS estimate, this quarter
−52%
estimate change, 90 days
1↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Next Q$0.28$0.28–$0.28-7.7%$916.7M
Current Q$0.05$0.05–$0.05+114.3%$842.1M
Next FY$1.90$1.90–$1.90+1.1%$4.1B
Current FY$0.91$0.91–$0.91-19.8%$3.7B
Congressional trades
EXAS trades disclosed by members of Congress, with disclosure delay.
1 members · 0 buys / 1 sells
DateMemberType AmountDisclosed
Mar 24, 2026 Kevin HernRHouse Child account · Exact Sciences Corporation SELL $1K–$15K Apr 3, 2026 +10d
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Aug 4, 2026 Earnings calendar
EXAS Q2 2026 Earnings After Market Close, 2026-08-04
Jul 29, 2026 SEC
The U.S. District Court for the Western District of Pennsylvania partially granted and partially denied Exact…
COURT-RULING · Impact 2/10
Jul 29, 2026 Event
SULLIVAN v. EXACT SCIENCES CORPORATION
Court ruling (pawd), Docket: 3:22-cv-00116
Jun 30, 2026 Inst.
NORGES BANK · EXIT
0 shares ($0.00)
Jun 12, 2026 SEC
26 institutions net purchased $269M of EXAS in Q3, led by Ameriprise (+$214.7M), Schroder (+$28.8M), and Soros…
INST-CLUSTER · Impact 5/10
Apr 2, 2026 SEC
Exact Sciences Corporation is deregistering its securities and terminating its SEC reporting obligations, citing fewer…
15-12G · Impact 7/10
Mar 31, 2026 Inst.
VAN ECK ASSOCIATES CORP · NEAR_EXIT
20,917 shares ($2.2M)
Mar 24, 2026 Congress
Kevin Hern sell
$1,001 - $15,000 · House
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 4, 2026
Earnings date
EXAS Q2 2026 Earnings After Market Close, 2026-08-04
Jul 29, 2026
Enforcement
SULLIVAN v. EXACT SCIENCES CORPORATION
Court ruling (pawd), Docket: 3:22-cv-00116
Apr 29, 2026
Earnings date
EXAS Q1 2026 Earnings After Market Close, 2026-04-29
Mar 23, 2026
Short interest
FTD: EXAS, 6,494 shares ($0.7M) failed to deliver
Settlement: 20260323, Price: $104.91, FTD Value: $681,285.54, EXACT SCIENCES CORPORATION
Mar 3, 2026
Short interest
FTD: EXAS, 55,749 shares ($5.8M) failed to deliver
Settlement: 20260303, Price: $103.35, FTD Value: $5,761,659.15, EXACT SCIENCES CORPORATION

Washington

Corporate Lobbying

23 lobbying filings and 8 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

SecBot reports

4 filings · 1 bullish · 1 bearish · 1 mixed · 1 neutral
All EXAS filing & press-release reports (4)